GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clearmind Medicine Inc (NAS:CMND) » Definitions » Shares Buyback Ratio %

Clearmind Medicine (Clearmind Medicine) Shares Buyback Ratio % : -3,736.79 (As of Jun. 18, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Clearmind Medicine Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Clearmind Medicine's current shares buyback ratio was -3,736.79%.


Clearmind Medicine Shares Buyback Ratio % Historical Data

The historical data trend for Clearmind Medicine's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clearmind Medicine Shares Buyback Ratio % Chart

Clearmind Medicine Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Shares Buyback Ratio %
Get a 7-Day Free Trial - -73.24 -95.18 -5.52 -1,280.63

Clearmind Medicine Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -87.79 -182.29 -1.75 -155.97 -421.88

Clearmind Medicine Shares Buyback Ratio % Calculation

Clearmind Medicine's Shares Buyback Ratio for the fiscal year that ended in Oct. 2023 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Oct. 2022 ) - Shares Outstanding (EOP) (A: Oct. 2023 )) / Shares Outstanding (EOP) (A: Oct. 2022 )
=(0.04399 - 0.60734) / 0.04399
=-1,280.63%

Clearmind Medicine's Shares Buyback Ratio for the quarter that ended in Jan. 2024 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Oct. 2023 ) - Shares Outstanding (EOP) (A: Jan. 2024 )) / Shares Outstanding (EOP) (A: Oct. 2023 )
=(0.60734 - 3.16957) / 0.60734
=-421.88%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Clearmind Medicine Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Clearmind Medicine's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Clearmind Medicine (Clearmind Medicine) Business Description

Traded in Other Exchanges
Address
101-1220 West 6th Avenue, Vancouver, BC, CAN, V6H 1A5
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.